You have successfully logged out.

Hello !
Logout
close

No content results match your keyword.

Content

    No product results match your keyword.

    Products

      Help prevent and treat diabetic foot ulcers

      Risk of diabetic foot syndrome

      Diabetic foot syndrome (DFS) is a common complication of diabetes mellitus that affects every fourth patient with diabetes at some point in their life.[1] The risk of developing DFS increases with time.

      Skin integrity of the foot

      Help to prevent the formation of diabetes foot ulcers

      foot illustration

      Linovera product range
      Askina Heel dressing

      Treatment guide

      Depending on the extent of the tissue damage, diabetic foot ulcers can be categorized into five grades, with every grade requiring its specific treatment.[13,14,15]

      diabetic foot ulcer illustration grade 1

      Prontosan product range
      Askina Calgitrol paste
      Askina DresSil Border foam dressing

      diabetic foot ulcer illustration grade 2

      Prontosan product range
      Askina Calgitrol range
      Askina Sorb and Askina DresSil

      diabetic foot ulcer illustration grade 3

      Prontosan product range
      Askina Calgitrol range
      Askina foam dressing
      Askina Carbosorb dressing

      diabetic foot ulcer illustration grade 4

      Prontosan product range
      Askina Calgitrol range
      Askina foam dressing
      Askina Carbosorb dressing

      Success story

      Rescue from amputation

      Do you know the story of Galo, the man whose foot amputation was avoided by a B. Braun sales rep?

      Find out more about how wound management with Prontosan® and Askina® changed the situation.

      Read the story

      Our product portfolio

      [1] Rümenapf G, Morbach S, Rother U, Uhl C, Görtz H, Böckler D, Behrendt CA, Hochlenert D, Engels G, Sigl M; Kommission PAVK und Diabetisches Fußsyndrom der DGG e. V.. Diabetisches Fußsyndrom – Teil 1 : Definition, Pathophysiologie, Diagnostik und Klassifikation [Diabetic foot syndrome-Part 1 : Definition, pathophysiology, diagnostics and classification]. Chirurg. 2021 Jan;92(1):81-94. German. doi: 10.1007/s00104-020-01301-9. PMID: 33170315; PMCID: PMC7819949.

      [2] Sommer TC, Lee TH. Charcot foot: the diagnostic dilemma. Am Fam Physician. 2001 Nov 1;64(9):1591-8. Erratum in: Am Fam Physician 2002 Jun 15;65(12):2436-8. PMID: 11730314.

      [3] Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 2012 Jun;11(6):521-34. doi: 10.1016/S1474-4422(12)70065-0. Epub 2012 May 16. PMID: 22608666; PMCID: PMC4254767.

      [4] Takeo M, Lee W, Ito M. Wound healing and skin regeneration. Cold Spring Harb Perspect Med. 2015 Jan 5;5(1):a023267. doi: 10.1101/cshperspect.a023267. PMID: 25561722; PMCID: PMC4292081.

      [5] Lauterbach S, Kostev K, Kohlmann T. Prevalence of diabetic foot syndrome and its risk factors in the UK. J Wound Care. 2010 Aug;19(8):333-7. doi: 10.12968/jowc.2010.19.8.77711. PMID: 20852505

      [6] Sämann A, Tajiyeva O, Müller N, Tschauner T, Hoyer H, Wolf G, Müller UA. Prevalence of the diabetic foot syndrome at the primary care level in Germany: a cross-sectional study. Diabet Med. 2008 May;25(5):557-63. doi: 10.1111/j.1464-5491.2008.02435.x. Epub 2008 Mar 14. PMID: 18346154.

      [7] Strain WD, Paldánius PM. Diabetes, cardiovascular disease and the microcirculation. Cardiovasc Diabetol. 2018 Apr 18;17(1):57. doi: 10.1186/s12933-018-0703-2. Erratum in: Cardiovasc Diabetol. 2021 Jun 11;20(1):120. PMID: 29669543; PMCID: PMC5905152.

      [8]. see current IFU Linovera®

      [9] see current IFU Linovera® Emulsion

      [10] see current IFU Askina® Heel

      [11] Olm M, Kühnl A, Knipfer E, Salvermoser M, Eckstein HH, Zimmermann A. Operative Versorgung von Diabetikern mit vaskulären Komplikationen : Sekundärdatenanalyse der DRG-Statistik von 2005 bis 2014 in Deutschland [Operative treatment of diabetics with vascular complications : Secondary data analysis of diagnosis-related groups statistics from 2005 to 2014 in Germany]. Chirurg. 2018 Jul;89(7):545-551. German. doi: 10.1007/s00104-018-0628-z. PMID: 29589075

      [12] Narres M, Kvitkina T, Claessen H, Droste S, Schuster B, Morbach S, Rümenapf G, Van Acker K, Icks A. Incidence of lower extremity amputations in the diabetic compared with the non-diabetic population: A systematic review. PLoS One. 2017 Aug 28;12(8):e0182081. doi: 10.1371/journal.pone.0182081. PMID: 28846690; PMCID: PMC5573217.

      [13] Jeon BJ, Choi HJ, Kang JS, Tak MS, Park ES. Comparison of five systems of classification of diabetic foot ulcers and predictive factors for amputation. Int Wound J. 2017 Jun;14(3):537-545. doi: 10.1111/iwj.12642. Epub 2016 Oct 10. PMID: 27723246; PMCID: PMC7949506.

      [14] Santema TB, Lenselink EA, Balm R, Ubbink DT. Comparing the Meggitt-Wagner and the University of Texas wound classification systems for diabetic foot ulcers: inter-observer analyses. Int Wound J. 2016 Dec;13(6):1137-1141. doi: 10.1111/iwj.12429. Epub 2015 Feb 26. PMID: 25720543; PMCID: PMC7949589.

      [15] Wagner FW. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle 1981;2

      [16]  see current IFU Prontosan® Wound Irrigation Solution

      [17]  see current IFU Prontosan® Wound Gel X

      [18]  see current IFU Prontosan® Debridement Pad

      [19]  see current IFU Askina® Calgitrol Paste

      [20]  see current IFU Askina® DresSil Border

      [21]  see current IFU Askina® Calgitrol AG

      [22]  see current IFU Askina® Sorb 

      [23]  see current IFU Askina® DresSil

      [24]  see current IFU Askina® Foam

      [25]  see current IFU Askina® Carbosorb